Raymond James: Fate Therapeutics & Ocata Expected To Beat Market By: Benzinga via Benzinga October 06, 2015 at 10:25 AM EDT Fate Therapeutics Inc (NASDAQ: FATE) shares are down 5 percent since July 7, while shares of Ocata Therapeutics Inc (NASDAQ: ... Read More >> Related Stocks: Fate Therapeutics